Due to the limited number of high-quality RCTs, large-scale, high-quality clinical trials are necessary to demonstrate the efficacy of neutrophil elastase inhibitors in adult patients with ARDS. This evidence concerns the gene ELANE and acute respiratory distress syndrome.